IS5220A - Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum - Google Patents

Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum

Info

Publication number
IS5220A
IS5220A IS5220A IS5220A IS5220A IS 5220 A IS5220 A IS 5220A IS 5220 A IS5220 A IS 5220A IS 5220 A IS5220 A IS 5220A IS 5220 A IS5220 A IS 5220A
Authority
IS
Iceland
Prior art keywords
carprofen
oxygenase
cyclo
dogs
inflammation
Prior art date
Application number
IS5220A
Other languages
English (en)
Inventor
Marie Lundy Kristin
Paul Ricketts Anthony
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS5220A publication Critical patent/IS5220A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
IS5220A 1997-05-05 1999-10-19 Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum IS5220A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (1)

Publication Number Publication Date
IS5220A true IS5220A (is) 1999-10-19

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5220A IS5220A (is) 1997-05-05 1999-10-19 Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum

Country Status (32)

Country Link
EP (1) EP0988034A1 (is)
JP (1) JP2000513020A (is)
KR (2) KR20010012300A (is)
CN (1) CN1255059A (is)
AP (1) AP9801234A0 (is)
AR (2) AR011726A1 (is)
AU (1) AU6932198A (is)
BG (1) BG103852A (is)
BR (1) BR9808720A (is)
CA (1) CA2288759A1 (is)
DZ (1) DZ2479A1 (is)
EA (1) EA003696B1 (is)
GT (1) GT199800063A (is)
HR (1) HRP980244A2 (is)
HU (1) HUP0001286A3 (is)
ID (1) ID21311A (is)
IL (1) IL132570A0 (is)
IS (1) IS5220A (is)
MA (1) MA26491A1 (is)
NO (1) NO995389L (is)
NZ (1) NZ500183A (is)
OA (1) OA11213A (is)
PA (1) PA8450601A1 (is)
PE (1) PE72599A1 (is)
PL (1) PL337003A1 (is)
SK (1) SK148199A3 (is)
TN (1) TNSN98059A1 (is)
TW (1) TW590773B (is)
UY (1) UY24989A1 (is)
WO (1) WO1998050033A1 (is)
YU (1) YU55899A (is)
ZA (1) ZA983722B (is)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU764872B2 (en) * 1998-10-23 2003-09-04 Merck Frosst Canada & Co. Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
CA2363590A1 (en) * 1999-03-10 2000-09-14 G.D. Searle & Co. Method and composition for administering a cyclooxygenase-2 inhibitor
WO2001034204A1 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
EP1283723A2 (en) * 2000-05-15 2003-02-19 Merck Frosst Canada & Co. Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
CN100588395C (zh) 2000-06-13 2010-02-10 Wyeth公司 含有环氧化酶-2抑制剂的止痛和抗炎药物
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
AU8474701A (en) 2000-08-07 2002-02-18 Univ Vanderbilt Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites
AU2002354901A1 (en) * 2001-07-16 2003-03-03 Edward Hogestatt Compounds with analgesic, antipyretic and/or anti-inflammatory activity
PT1534305E (pt) 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
JP2007500691A (ja) * 2003-07-31 2007-01-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗炎症剤の分散性製剤
BRPI0610316A2 (pt) * 2005-05-20 2010-06-15 Pfizer Ltd combinações sinergìsticas de medicamentos atiinflamatórios não estereoidais com alfa-delta-ligantes
EP2061440A2 (en) 2007-04-04 2009-05-27 Sigmoid Pharma Limited A pharmaceutical composition of tacrolimus
ES2963291T3 (es) 2007-04-26 2024-03-26 Sublimity Therapeutics Ltd Fabricación de múltiples minicápsulas
EP2471518B1 (en) 2009-05-18 2017-08-23 Sigmoid Pharma Limited Composition comprising oil drops
EP2464341B1 (en) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
TWI664969B (zh) 2014-03-06 2019-07-11 雅瑞塔那醫療公司 格拉匹綸(grapiprant)組合物及其使用方法
WO2016071515A1 (en) 2014-11-07 2016-05-12 Sigmoid Pharma Limited Compositions comprising cyclosporin
EP3242557A4 (en) * 2015-01-09 2018-09-05 Jaguar Health, Inc. Methods of treating diarrhea in companion animals
CN115335046A (zh) * 2020-03-25 2022-11-11 思研(Sri)国际顾问与咨询公司 脂肪氧合酶抑制剂
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
JP2000513020A (ja) 2000-10-03
ZA983722B (en) 1999-11-04
SK148199A3 (en) 2001-09-11
BG103852A (en) 2000-06-30
AR011726A1 (es) 2000-08-30
EP0988034A1 (en) 2000-03-29
CN1255059A (zh) 2000-05-31
HRP980244A2 (en) 1999-02-28
WO1998050033A1 (en) 1998-11-12
KR20040004406A (ko) 2004-01-13
NO995389D0 (no) 1999-11-04
AU6932198A (en) 1998-11-27
OA11213A (en) 2003-07-14
KR20010012300A (ko) 2001-02-15
HUP0001286A2 (hu) 2000-11-28
EA199900895A1 (ru) 2000-06-26
YU55899A (sh) 2003-08-29
EA003696B1 (ru) 2003-08-28
HUP0001286A3 (en) 2000-12-28
TNSN98059A1 (fr) 2005-03-15
TW590773B (en) 2004-06-11
PL337003A1 (en) 2000-07-31
MA26491A1 (fr) 2004-12-20
BR9808720A (pt) 2000-07-11
AP9801234A0 (en) 1999-11-04
UY24989A1 (es) 2001-10-25
PE72599A1 (es) 1999-08-12
NZ500183A (en) 2002-04-26
CA2288759A1 (en) 1998-11-12
NO995389L (no) 2000-01-04
AR039628A2 (es) 2005-03-02
IL132570A0 (en) 2001-03-19
ID21311A (id) 1999-05-20
GT199800063A (es) 1999-10-26
PA8450601A1 (es) 2000-05-24
DZ2479A1 (fr) 2003-02-01

Similar Documents

Publication Publication Date Title
NO995389D0 (no) COX-2-selektiv carprofen for behandling av smerte og betennelse i hunder
NO20005190L (no) Terapeutiske angiogene faktorer og fremgangsmåter til anvendelse derav
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
IS5405A (is) Prostaglandín gerandefni og notkun þeirra til að meðhöndla beintruflanir
DE69825447D1 (de) Gerät zur dermatologischen behandlung
IS2107B (is) Arýlsúlfónamíð og hliðstæður þeirra og notkun þeirra við meðhöndlun taugahrörnunarsjúkdóma
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
NO983576D0 (no) Brönnbehandlingsfluider og fremgangsmåter
NO20022656L (no) Caspaseinhibitorer og anvendelse derav
IS5921A (is) Staðgengnar Bensópýrahliðstæður til notkunar við meðhöndlun á bólgu
DE69911221D1 (de) Methode und gerät zur darreichung von therapeutischen mitteln in verbindung mit dem plazieren von radioaktiven körnern
IS5928A (is) Aðferðir og samsetningar til að hindra lyfjaþol
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
DE60019490D1 (de) Brennstofförder-und behandlungsvorrichtung
ID18741A (id) Zat nikotinat dalam terapi
DE69701250D1 (de) Tierbehandlungsvorrichtung
IS4628A (is) Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársauka
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
NO20012738D0 (no) Terapeutiske produkter og anvendelse derav
IS5809A (is) Samtíma inngjöf ACAT og MMP tálma til meðhöndlunar á skemmdum vegna fituhrörnunar
ITMI20001555A0 (it) Procedimento e dispositivo di trattamento elettrochimico
DE69932577D1 (de) Stangenbehandlungsgerät und Stangenladegerät
DK0915655T3 (da) Fremgangsmåde og sammensætning til behandling mod parasitter i dyrs omgivelser
IS6428A (is) Aðferð og blanda til að meðhöndla sársauka
IS5324A (is) (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka